Content about Anabolic steroids

October 16, 2012
Manning up

Natural Products Solutions recently announced the launch of VirMax T Testosterone. As part of that launch, DSN caught up with NPS president and CEO Marty Gallant to discuss men’s health supplements.

AUDIO Q&A: DSN caught up with Marty Gallant, Natural Products Solutions president and CEO, which recently announced the launch of VirMax T Testosterone, to discuss men’s health supplements.

April 1, 2013
Actavis seeks approval for additional strength of generic testosterone gel

Just a week after the Supreme Court heard the Federal Trade Commission's lawsuit over its deal with AbbVie to sell a generic version of a testosterone-replacement therapy, Actavis is challenging the patent on another strength of the drug.

PARSIPPANY, N.J. — Just a week after the Supreme Court heard the Federal Trade Commission's lawsuit over its deal with AbbVie to sell a generic version of a testosterone-replacement therapy, Actavis is challenging the patent on another strength of the drug.

Actavis said Monday that it had filed with the Food and Drug Administration for approval of testosterone gel in the 1.62% strength. The drug is a generic version of AbbVie's AndroGel 1.62%. The case that went before the Supreme Court on March 25 concerns the 1% strength of AndroGel.

March 15, 2013
FDA approves new packet version of AbbVie testosterone gel

The Food and Drug Administration has approved a new pocket-sized packet option for a testosterone-replacement therapy made by AbbVie, the drug maker said Friday.

CHICAGO — The Food and Drug Administration has approved a new pocket-sized packet option for a testosterone-replacement therapy made by AbbVie, the drug maker said Friday.

AbbVie announced the approval of the new version of AndroGel (testosterone) 1.62%, available in a packet containing 40.5 mg of testosterone in 2.5 g of gel and a packet with 20.25 mg of testosterone in 1.25 g of gel. The drug is used to raise testosterone levels in men with low or no testosterone, known as hypogonadism, estimated to affect nearly 14 million men in the United States.

March 5, 2013
Actavis seeks approval for testosterone-replacement gel

Drug maker Actavis is challenging the patent for a drug used to treat testosterone deficiency or absence in men, the company said.

PARSIPPANY, N.J. — Drug maker Actavis is challenging the patent for a drug used to treat testosterone deficiency or absence in men, the company said.

Actavis, formerly known as Watson Pharmaceuticals, said it had filed a regulatory approval application with the Food and Drug Administration for a generic version of Endo Pharmaceuticals' Fortesta (testosterone) gel in the 10 mg-per-0.5 g strength.

February 5, 2013
FDA approves Perrigo testosterone gel

The Food and Drug Administration has approved a testosterone gel product made by Perrigo, the drug maker said.

ALLEGAN, Mich. — The Food and Drug Administration has approved a testosterone gel product made by Perrigo, the drug maker said Tuesday.

Perrigo announced the approval of the testosterone gel in the 1% strength for the treatment of men with low or no testosterone.

The drug is bioequivalent to AbbVie's AndroGel, which has annual sales of about $705 million, according to Symphony Health.

January 9, 2013
Four-time NBA champion John Salley to headline VirMax at industry event

Four-time NBA champion John Salley will be heading here next week to attend the ECRM Vitamin, Diet and Sports Nutrition conference in support of Natural Product Solutions.

SAN ANTONIO, Texas — Four-time NBA champion John Salley will be heading here next week to attend the ECRM Vitamin, Diet and Sports Nutrition conference in support of Natural Product Solutions. 

Salley is NPS' spokesman for VirMax, a line that consists of five supplement products that are formulated to benefit health levels of testosterone, a healthy prostate and other men’s health issues.

September 27, 2012
Natural Products Solutions expands men's health supplement line with VirMax T

Natural Products Solutions recently announced the launch of VirMax T testosterone booster as the newest addition to the VirMax line of supplements.

TIMONIUM, Md. — Natural Products Solutions recently announced the launch of VirMax T testosterone booster as the newest addition to the VirMax line of supplements. VirMax T made its official debut in early October at the 2012 National Association of Convenience Stores in Las Vegas and it currently is available in Circle K stores nationwide and on Walgreens' Drugstore.com site.

August 17, 2012
Supplement industry fights for awareness

The September 2012 issue of Consumer Reports revealed that the dietary supplement industry still has a tough road to hoe in distancing responsible players in the nutritional sector from those purveyors of illegally marketed drugs and other quackery products. 


The September 2012 issue of Consumer Reports revealed that the dietary supplement industry still has a tough road to hoe in distancing responsible players in the nutritional sector from those purveyors of illegally marketed drugs and other quackery products. 


July 26, 2012
Bipartisan bill will give DEA broader powers to stop steroids sold as supplements

Sens. Orrin Hatch, R-Utah, and Sheldon Whitehouse, D-R.I., on Wednesday introduced the Designer Anabolic Steroid Control Act, a bill that will protect consumers by providing the Drug Enforcement Administration with new enforcement tools to identify and quickly respond when new designer anabolic steroids are created and marketed as dietary supplements.

WASHINGTON — Sens. Orrin Hatch, R-Utah, and Sheldon Whitehouse, D-R.I., on Wednesday introduced the Designer Anabolic Steroid Control Act, a bill that will protect consumers by providing the Drug Enforcement Administration with new enforcement tools to identify and quickly respond when new designer anabolic steroids are created and marketed as dietary supplements.

May 21, 2012
GSK, Auxilium to co-promote testosterone therapy

The U.S. subsidiary of British drug maker GlaxoSmithKline and U.S.-based Auxilium Pharmaceuticals will co-promote a testosterone-replacement drug, the two said Monday.

MALVERN, Pa. — The U.S. subsidiary of British drug maker GlaxoSmithKline and U.S.-based Auxilium Pharmaceuticals will co-promote a testosterone-replacement drug, the two said Monday.

GSK and Auxilium announced an agreement for the co-promotion of Testim 1% (testosterone gel), used in men with conditions related to deficiency or absence of the hormone.

November 2, 2011
Perrigo seeks approval for generic version of Abbott's Androgel

Drug maker Perrigo has filed for regulatory approval of a generic topical drug for treating testosterone deficiency, prompting a patent infringement suit from the branded version's manufacturer.

ALLEGAN, Mich. — Drug maker Perrigo has filed for regulatory approval of a generic topical drug for treating testosterone deficiency, prompting a patent infringement suit from the branded version's manufacturer.

October 21, 2011
FDA approves new formulation of Watson's Androderm

The Food and Drug Administration has approved a new formulation of a testosterone therapy made by Watson Pharmaceuticals, the drug maker said Friday.

PARSIPPANY, N.J. — The Food and Drug Administration has approved a new formulation of a testosterone therapy made by Watson Pharmaceuticals, the drug maker said Friday.

Watson announced the approval of its Androderm (testosterone) transdermal system in the 2-mg and 4-mg formulation. The company said the new smaller size and lower-dose patch would provide "highly effective" testosterone administration with a 20% reduction in the active ingredient from the original strength. Watson plans to launch the new patch next month.

May 2, 2011
FDA approves Abbott's AndroGel

The Food and Drug Administration has approved a treatment made by Abbott for low testosterone in men, the drug maker said Friday.

ABBOTT PARK, Ill. — The Food and Drug Administration has approved a treatment made by Abbott for low testosterone in men, the drug maker said Friday.

Abbott announced the approval of AndroGel (testosterone gel) in the 1.62% strength, a clear, odorless topical gel for men with hypogonadism. The company already markets AndroGel in the 1% strength.

The new gel contains 40.5 mg of testosterone in two pump presses, while AndroGel 1% contains 50 mg in four pump presses, but the company said the two were not interchangeable.

April 13, 2011
FDA accepts regulatory application for Bio-T-Gel

The Food and Drug Administration has accepted a regulatory approval application for a topical treatment for low testosterone made by Teva Pharmaceuticals and BioSante Pharmaceuticals, BioSante said Wednesday.

LINCOLNSHIRE, Ill. — The Food and Drug Administration has accepted a regulatory approval application for a topical treatment for low testosterone made by Teva Pharmaceuticals and BioSante Pharmaceuticals, BioSante said Wednesday.

The two companies said the FDA had accepted their application for Bio-T-Gel and expected to complete its review by mid-November.

March 3, 2011
Endo launches Fortesta

Endo Pharmaceuticals has launched a recently approved testosterone gel for men.

CHADDS FORD, Pa. — Endo Pharmaceuticals has launched a recently approved testosterone gel for men.

Endo announced Thursday the launch of Fortesta, approved by the Food and Drug Administration for treating low testosterone — or low T — in men, which affects about 14 million men in the United States; around 1.3 million of those men currently are receiving treatment, according to Endo.

January 4, 2011
Endo's Fortesta receives FDA approval

The Food and Drug Administration has approved a topical testosterone replacement therapy made by Endo Pharmaceuticals, Endo said last week.

CHADDS FORD, Pa. — The Food and Drug Administration has approved a topical testosterone replacement therapy made by Endo Pharmaceuticals, Endo said last week.

The drug maker announced on Dec. 29 the approval of Fortesta (testosterone) gel, a treatment for men with low testosterone, which affects nearly 14 million men in the United States.

Endo said it planned to introduce Fortesta in the United States early this year.

November 24, 2010
FDA approves Axiron

Eli Lilly and Australian drug maker Acrux have received approval from the Food and Drug Administration for a testosterone replacement therapy for men, the two companies announced Tuesday.

INDIANAPOLIS — Eli Lilly and Australian drug maker Acrux have received approval from the Food and Drug Administration for a testosterone replacement therapy for men, the two companies announced Tuesday.

The FDA approved Axiron (testosterone) topical solution as a treatment for men with various conditions that lead to deficiency of the hormone. The drug, a controlled substance, is designed for application under the arm.

June 30, 2010
Endo resubmits application for approval for Fortesta

Endo Pharmaceuticals has resubmitted its application to the Food and Drug Administration for a testosterone...

December 6, 2009
USADA develops 'Supplement Safety Now' initiative

Ignorance is not always bliss. For as much such associations as the Natural Products Association...

NEW YORK Ignorance is not always bliss. For as much such associations as the Natural Products Association and the Council for Responsible Nutrition assert that the dietary supplement business is in fact regulated, there still are a host of organizations that ought to know better, suggesting it isn’t.

If “Supplement Safety Now” is successful, it stands to increase the cost of doing business for retailers and supplement suppliers without making one dent into the illicit business of steroids.